Top Markets
Coin of the day
Hubei Biocause Heilen Pharmaceutical Co., Ltd. Hubei Biocause Heilen Pharmaceutical Co., Ltd.

Hubei Biocause Heilen Pharmaceutical Co., Ltd.

301211
Rank in Stocks #10977
Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with... Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with diverse operations spanning the pharmaceutical, chemical, and new energy fuel sectors. Within its pharmaceutical segment, the company manufactures active pharmaceutical ingredients (APIs), various intermediates, and finished drug formulations. Furthermore, its chemical offerings include industrial products such as dimethyl ether gas and chloropropionyl chloride. The firm is headquartered in Jingmen, China.
Share Price
$1.82
Last synced: 2026-08-28
Market Cap
$760.08M
Change (1 day)
-3.16%
Change (1 year)
3.42%
Country
CN
Trade Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211)

Category

P/B ratio for Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211)
P/B ratio as of 2026 TTM: 0
According to Hubei Biocause Heilen Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Hubei Biocause Heilen Pharmaceutical Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors